Follicular lymphoma - rituximab

Rituximab for the treatment of follicular lymphoma

Summary

Rituximab (given with cyclophosphamide, vincristine and prednisolone) is recommended as a possible treatment for people with symptomatic stage III or IV follicular lymphoma who haven't been treated before.

Guidance documents

• Guidance PDF format
• Quick reference guide PDF format
• Understanding NICE guidance PDF format
• TA110 Follicular lymphoma - rituximab: guidance (MS Word format)
• TA110 Follicular lymphoma - rituximab: understanding NICE guidance (MS Word format)

Implementing this guidance

• Cost report
• Audit criteria

• How this guidance was produced
• Background information

We will consult on our review plans for this guidance in June 2009